Acute kidney injury requiring dialysis and in‐hospital mortality in patients with chronic kidney disease and non–ST‐segment elevation acute coronary syndrome undergoing early vs delayed percutaneous coronary intervention: A nationwide analysis

By  

Clinical Cardiology, Vol. 40, Iss. 12, 2017-12 ,pp. : 1303-1308

John Wiley & Sons Inc

Access to resources Recommend Favorite

Comparative Pharmacodynamic Evaluation of Eptifibatide and Abciximab in Patients with Non-ST-Segment Elevation Acute Coronary Syndromes: The TAM2 Study

By Saucedo Jorge F.   Lui Henry K.   Garza Luis   Guerra G. Jose   Jacoski Mary V.   Jennings Lisa K.  

Journal of Thrombosis and Thrombolysis, Vol. 18, Iss. 2, 2004-10 ,pp. : 67-74

Springer Publishing Company

Access to resources Recommend Favorite

Efficacy and Safety of Vorapaxar in Non–ST‐Segment Elevation Acute Coronary Syndrome Patients Undergoing Noncardiac Surgery

By  

JOURNAL OF THE AMERICAN HEART ASSOCIATION, Vol. 4, Iss. 12, 2015-12 ,pp. : n/a-n/a

John Wiley & Sons Inc

Access to resources Recommend Favorite

Practical approach to incorporating new studies and guidelines for antiplatelet therapy in the management of patients with non-ST-segment elevation acute coronary syndrome

By Boden W.E.  

The American Journal of Cardiology, Vol. 93, Iss. 1, 2004-01 ,pp. : 69-72

Elsevier

Access to resources Recommend Favorite

Japanese postmarketing surveillance of clopidogrel for patients with non-ST-segment-elevation acute coronary syndrome indicated for percutaneous coronary intervention (J-PLACE NSTE-ACS)

By Morino Yoshihiro   Ako Junya   Kobayashi Masayuki   Nakamura Masato  

Cardiovascular Intervention and Therapeutics, Vol. 29, Iss. 2, 2014-04 ,pp. : 123-133

Springer Publishing Company

Access to resources Recommend Favorite